Viewing StudyNCT00228358



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00228358
Status: COMPLETED
Last Update Posted: 2014-11-11
First Post: 2005-09-13

Brief Title: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patients Own T Cells in the Laboratory in Treating Patients With HER-2Neu Overexpressing Metastatic Breast Cancer Ovarian Cancer or Non-Small Cell Lung Cancer Previously Treated With HER-2Neu Vaccine
Sponsor:
Organization: University of Washington